
|Articles|October 1, 2002
In the pipeline: B&L, InSite to develop compound for infections
San Dimas, CA-Bausch & Lomb and InSite Vision will develop a fourth-generation fluoroquinolone that incorporates InSite Vision's drug delivery system, DuraSite.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
3
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
4
Eye exams could enable earlier detection of systemic disease
5



























